[{"NetIncomeLoss_2_Q2_USD":-80185000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":13688000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":170919000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1337000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":78126000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":12694000.0,"AssetsCurrent_0_Q2_USD":218954000.0,"OperatingLeaseExpense_2_Q2_USD":2800000.0,"OperatingLeaseExpense_1_Q2_USD":1400000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":27866000.0,"LongTermDebtFairValue_0_Q2_USD":45600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":26868000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4616000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":658000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-276000.0,"EquitySecuritiesFvNi_0_Q2_USD":1300000.0,"Assets_0_Q2_USD":232495000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-276000.0,"ShareBasedCompensation_2_Q2_USD":8051000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3334000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":373200000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":59438.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21790000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":223734000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":107897000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":300000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":700000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1454000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2254000.0,"CommonStockValue_0_Q2_USD":60000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":16648000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":824000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":59605.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":4149000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-79527000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-41056000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":61134000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":591000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":865724000.0,"Liabilities_0_Q2_USD":310575000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":1998000.0,"OperatingLeaseLiability_0_Q2_USD":5666000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":26610000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14161000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":43528000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":401000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":160000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-57574000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":22696000.0,"AccountsPayableCurrent_0_Q2_USD":2920000.0,"NonoperatingIncomeExpense_2_Q2_USD":2105000.0,"NonoperatingIncomeExpense_1_Q2_USD":1382000.0,"InterestExpense_2_Q2_USD":7969000.0,"InterestExpense_1_Q2_USD":3892000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3637000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4527000.0,"LongTermDebtNoncurrent_0_Q2_USD":45631000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.09,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":61134000.0,"ProceedsFromDebtNetOfIssuanceCosts_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":826000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":3600000.0,"DebtSecuritiesAvailableForSaleGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleGainLoss_1_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5611000.0,"NetIncomeLoss_1_Q2_USD":-40780000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2557000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":16195000.0,"AmortizationOfFinancingCosts_1_Q2_USD":19000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-2909000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-5240000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7418000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3593000.0,"OperatingIncomeLoss_2_Q2_USD":-62720000.0,"OperatingIncomeLoss_1_Q2_USD":-32358000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":151929000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q2_USD":0.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":232495000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7476000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5075000.0,"OperatingExpenses_1_Q2_USD":35951000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1106000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.35,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.68,"ProfitLoss_2_Q2_USD":-80185000.0,"OtherLiabilitiesCurrent_0_Q2_USD":1013000.0,"StockholdersEquity_0_Q2_USD":-78080000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1905000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-945201000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":24701000.0,"OperatingExpenses_2_Q2_USD":70138000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2662000.0,"Ticker":"CYTK","CIK":"1061983","name":"CYTOKINETICS INC","OfficialName":"Cytokinetics Incorporated Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"3243164482.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]